Health insurance costs could soon rise in Pennsylvania; Here's why
PENNSYLVANIA (WHTM) – Pennie is urging congress to act now to prevent an increase in health coverage costs for Pennsylvanians.
Enhanced premium tax credits were enacted by the American Rescue Plan in 2021. It helps eligible people cover health insurance purchased through the insurance marketplace. This is set to expire at the of 2025.
'Pennie enrollment has grown about 50% since 2021, when these enhanced tax credits went into place,' said Pennie Executive Director, Devon Trolley.
In fact, Pennie ended its 2025 open enrollment with record-breaking enrollees, nearly half a million. That's a 14% increase from last year.
'If congress does not act in the coming months, the progress will not only stop but will start going in reverse,' said Trolley.
Trolley says Pennie enrollees will pay 82% more on average for health insurance. Many people could pay double or even four times more.
For example, Trolley says,'60-year-old couple in York County making $82,000. Their monthly premiums would go from about $600 today to $2,900 a month without the enhanced premium tax credits.'
That's 44% of their income. With cost increases, Trolley says those enrolled in Pennie will be faced with difficult decisions.
'Of how to continue coverage they can't afford or to go uninsured again and instead of having health and financial security they face brining their families back into uncertainty, risk, and fear of what happens if they have the misfortune of an illness or injury,' said Trolley.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
Treace Files Patent Infringement Suit Against Zimmer Biomet to Protect Lapiplasty® Bunion Technology
PONTE VEDRA, Fla., June 05, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ('Treace' or the 'Company') (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty® and Adductoplasty® procedures, today announced that it filed a lawsuit against Zimmer Biomet Holdings, Inc. and Paragon 28, Inc. (collectively, 'Zimmer') (NYSE: ZBH), alleging infringement of 4 patents related to Treace's innovative Lapiplasty® 3D Bunion Correction® technologies. The suit was filed in the United States District Court for the District of Delaware, and seeks injunctive relief and damages. 'Treace Medical was the first company to develop, patent, and introduce an instrumented 3D bunion correction system for true tri-planar lapidus bunion correction and is the recognized leader in the surgical treatment of bunions. We believe that this lawsuit is necessary to protect the significant investments we have made in our pioneering research and technology, which is in the best interest of our stockholders,' said John T. Treace, Chairman, CEO and Founder of Treace. 'Enforcing and defending our intellectual property helps to drive our ability to continue to innovate solutions that benefit patients.' Treace's patent portfolio includes 80 granted U.S. patents, with an additional 26 granted patents worldwide and over 150 pending patent applications. About Treace Medical Concepts Treace Medical Concepts, Inc. is a medical technology company with the goal of advancing the standard of care for the surgical management of bunion and related midfoot deformities. Bunions are complex 3-dimensional deformities that originate from an unstable joint in the middle of the foot and affect approximately 67 million Americans, of which Treace estimates 1.1 million are annual surgical candidates. Treace has pioneered and patented the Lapiplasty® 3D Bunion Correction® System – a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. To further support the needs of bunion patients, Treace has introduced its Adductoplasty® Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP™ Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty™ 3D Minimally Invasive Bunion Correction System and the Percuplasty™ Percutaneous 3D Bunion Correction System. The Company continues to expand its footprint in the foot and ankle market with the introduction of its SpeedPlate™ Rapid Compression Implants, an innovative fixation platform with broad versatility across Lapiplasty® and Adductoplasty® procedures, as well as other common bone fusion procedures of the foot. For more information, please visit To learn more about Treace, connect with us on LinkedIn, X, Facebook and Instagram. Contacts:Treace Medical ConceptsMark L. HairChief Financial Officermhair@ 373-5940 Investors:Gilmartin GroupPhilip Trip Taylor IR@
Yahoo
3 hours ago
- Yahoo
More Americans turning to weight loss drugs to shed weight
HARTFORD, Conn. (WTNH) — More Americans are turning to medical weight loss drugs to lose weight. Before you start, you may want to think about speaking with a registered dietitian nutritionist. Hartford HealthCare's Cody Krawec, a clinical nutrition manager at St. Vincent's Medical Center, joined Good Morning Connecticut at 9 a.m. to explain. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
3 hours ago
- Yahoo
Massive Beef Jerky Recall Issued After Undeclared Allergen Discovery
Springville Meat & Cold Storage Co., Inc. issued a recall of over 15,000 pounds of beef jerky because the products contain fish but do not declare it on the label. The recalled jerky was shipped to retail locations across the U.S. and includes multiple flavors and package sizes under various brand names. While no allergic reactions have been reported, the USDA urges consumers to discard the recalled jerky or return the product to its place of your pantry or snack drawer if you're a beef jerky fan. Roughly 15,388 pounds of ready-to-eat beef jerky and beef snack stick products have been recalled due to an undeclared fish allergen, according to the U.S. Department of Agriculture's Food Safety and Inspection Service (FSIS). The recall involves various brands of beef snack products manufactured by Springville Meat & Cold Storage Co., Inc. such as Uncommon Ground, Papa Ray's, Spear Cattle Co., Smokehouse Jerky Co., Dry Lakes Ranch, Twisselman Outfitters, and Wild Green Water Ranch. The items were sold at retail locations across the U.S. and were produced from May 30, 2023 to May 30, 2025. The packaging of the affected products bears an establishment number of "EST. 20528" inside the USDA mark of inspection. Images of the product labels, including the flavors and the type of jerky (elk, venison, and buffalo), can be found in the FSIS recall announcement. The recall was issued because the Worcestershire sauce used in the jerky and snack stick products contains anchovies, a known allergen not declared on the product label. Those with a fish allergy may experience an allergic reaction if they consume the recalled products. According to the American College of Allergy, Asthma & Immunology, symptoms can include hives or a skin rash, nausea, stomach cramps, indigestion, vomiting, diarrhea, a stuffy or runny nose and/or sneezing, headaches, and asthma. Anaphylaxis, a potentially life-threatening reaction that impairs breathing and can cause the body to go into shock, is also possible but is less common. There have been no confirmed reports of adverse reactions due to consumption of the recalled products. If you have these items in your pantry, throw them away or return them to the place of purchase immediately. Consumers can contact Ryan Cope, owner of Springville Meat & Cold Storage Co., Inc., at ryan@ with any questions. Read the original article on Martha Stewart
